Skip to content
Glycotope GmbH logo — Improving the lives of cancer patients by enabling treatment...

Glycotope GmbH

Improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care

Founded 2001 Germany Berlin, Germany 11 employees Biotechnology

General Information

Company Name Glycotope GmbH
Founded Year 2001
Location Germany Berlin, Germany
Employees 11
Industries Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with Glycotope GmbH. To contact Glycotope GmbH, visit glycotope.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Glycotope GmbH compare?

A PDF of Glycotope GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Glycotope GmbH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Glycotope GmbH

Glycotope GmbH is a biotechnology company founded in 2001 and headquartered in Germany. The company is committed to improving the lives of cancer patients by developing uniquely tumor-specific monoclonal antibodies using a proprietary technology platform. Their expertise in glycobiology and antibody development allows them to advance first-in-class antibody-based therapeutics for (immuno)-oncology. The company has discovered over 200 GlycoTargets and has several antibodies against selected targets under development. These antibodies have superior tumor-specificity and are suitable for development in various modes of action including naked antibodies, bispecifics, antibody-drug-conjugates, cellular therapies, or fusion proteins. With a clear focus on advancing cancer treatment options, Glycotope is poised to make significant contributions to the field of oncology.

Business keywords: Monoclonal Antibodies, Cancer Treatment, Glycobiology, Immunotherapy, Biopharmaceuticals, Recombinant Protein Production, GMP Compliance, Antibody Discovery, Oncology, Contract Manufacturing, Active Biopharmaceutical Ingredients, ISO 9001 Certification, Gene Technology, Protein Production

No funding data available for Glycotope GmbH yet.

Glycotope GmbH Alternatives & Competitors

View All Alternatives
Glycotope GmbH vs

Rely on us with your outsourcing needs

38 employees
Biotechnology, Health Care
Glycotope GmbH vs
iBio, Inc.
iBio, Inc. United States

AI-Powered Precision Antibody Therapeutics

Post-IPO Equity
50 employees
Biotechnology, Robotics
Glycotope GmbH vs
Aldevron
Aldevron United States

A world where every cure is possible.

Acquired
744 employees
Biotechnology, Industrial

FAQ About Glycotope GmbH

Improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care
Glycotope GmbH was founded in 2001.
Glycotope GmbH is headquartered in Berlin, Germany.
Glycotope GmbH operates in Biotechnology. Its work centres on Monoclonal Antibodies, Cancer Treatment, Glycobiology and Immunotherapy.
Glycotope GmbH has approximately 11 employees.
Top alternatives and competitors to Glycotope GmbH include InVivo BioTech Services GmbH - a Bruker Company, iBio, Inc., Aldevron, WuXi Biologics, Walking Fish Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glycotope GmbH and InVivo BioTech Services GmbH - a Bruker Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Glycotope GmbH, https://bouncewatch.com/company/glycotope-gmbh, updated 2 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout